|
US2490813A
(en)
|
1944-11-29 |
1949-12-13 |
Standard Oil Co |
Continuous process for making aryl amines
|
|
US3299078A
(en)
|
1962-10-01 |
1967-01-17 |
Smith Kline French Lab |
Pyrido [3', 4': 4, 5] pyrrolo [3, 2, 1-hi] indoles and-[3, 2, 1-ij] quinolines
|
|
US3813392A
(en)
|
1969-06-09 |
1974-05-28 |
J Sellstedt |
Pyrrolo(1,2,3-alpha epsilon)quinoxalin-2(3h)-ones and related compounds
|
|
US4238607A
(en)
|
1972-06-19 |
1980-12-09 |
Endo Laboratories Inc. |
Pyridopyrrolo benzheterocycles
|
|
US4001263A
(en)
|
1974-04-01 |
1977-01-04 |
Pfizer Inc. |
5-Aryl-1,2,3,4-tetrahydro-γ-carbolines
|
|
HU208484B
(en)
|
1988-08-17 |
1993-11-29 |
Chinoin Gyogyszer Es Vegyeszet |
Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
|
|
US5114976A
(en)
|
1989-01-06 |
1992-05-19 |
Norden Michael J |
Method for treating certain psychiatric disorders and certain psychiatric symptoms
|
|
US6407092B1
(en)
|
1999-04-23 |
2002-06-18 |
Pharmacia & Upjohn Company |
Tetracyclic azepinoindole compounds
|
|
US7071186B2
(en)
|
1999-06-15 |
2006-07-04 |
Bristol-Myers Squibb Pharma Co. |
Substituted heterocycle fused gamma-carbolines
|
|
WO2000077001A1
(en)
|
1999-06-15 |
2000-12-21 |
Du Pont Pharmaceuticals Company |
Substituted heterocycle fused gamma-carbolines
|
|
US6713471B1
(en)
|
1999-06-15 |
2004-03-30 |
Bristol-Myers Squibb Pharma Company |
Substituted heterocycle fused gamma-carbolines
|
|
US6849619B2
(en)
|
2000-12-20 |
2005-02-01 |
Bristol-Myers Squibb Company |
Substituted pyridoindoles as serotonin agonists and antagonists
|
|
RU2003121304A
(ru)
*
|
2000-12-20 |
2005-01-27 |
Бристол-Маерс Сквибб Компани (Us) |
Замещенные пиридоиндолы в качестве агонистов и антагонистов серотонина
|
|
US20050222209A1
(en)
|
2004-04-01 |
2005-10-06 |
Zeldis Jerome B |
Methods and compositions for the treatment, prevention or management of dysfunctional sleep and dysfunctional sleep associated with disease
|
|
US7592454B2
(en)
|
2004-04-14 |
2009-09-22 |
Bristol-Myers Squibb Company |
Substituted hexahydro-pyridoindole derivatives as serotonin receptor agonists and antagonists
|
|
WO2006034187A2
(en)
|
2004-09-20 |
2006-03-30 |
Mount Sinai School Of Medicine |
Use of memantine (namenda) to treat autism, compulsivity, and impulsivity
|
|
RU2401257C2
(ru)
|
2004-12-07 |
2010-10-10 |
Янссен Фармацевтика Н.В. |
Новые замещенные тетрациклические производные тетрагидрофурана, пирролидина и тетрагидротиофена
|
|
WO2008030651A1
(en)
|
2006-09-08 |
2008-03-13 |
Braincells, Inc. |
Combinations containing a 4-acylaminopyridine derivative
|
|
MX394214B
(es)
|
2007-03-12 |
2025-03-24 |
Intra Cellular Therapies Inc |
Sintesis de gamma-carbolinas fusionadas con heterociclo substituido.
|
|
CN101983058A
(zh)
|
2008-02-05 |
2011-03-02 |
克莱拉有限公司 |
缓解抑郁症或改善认知的组合物和方法
|
|
ES2530090T3
(es)
|
2008-03-12 |
2015-02-26 |
Intra-Cellular Therapies, Inc. |
Sólido de gamma-carbolinas fusionadas con heterociclo sustituido
|
|
CA2725342C
(en)
|
2008-05-27 |
2024-02-20 |
Intra-Cellular Therapies, Inc. |
Substituted heterocycle fused gamma-carbolines for sleep disorders and other disorders
|
|
US8993572B2
(en)
|
2010-04-22 |
2015-03-31 |
Intra-Cellular Therapies, Inc. |
Pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines derivatives and [1,4]oxazino[2,3,4-hi]pyrido[4,3-b]indole derivatives
|
|
TWI582092B
(zh)
|
2010-07-28 |
2017-05-11 |
歌林達股份有限公司 |
順式-四氫-螺旋(環己烷-1,1’-吡啶[3,4-b]吲哚)-4-胺-衍生物
|
|
US9737531B2
(en)
|
2012-07-12 |
2017-08-22 |
Glytech, Llc |
Composition and method for treatment of depression and psychosis in humans
|
|
JP5773781B2
(ja)
*
|
2011-06-30 |
2015-09-02 |
株式会社東芝 |
超音波診断装置、画像処理装置及びプログラム
|
|
AU2012295810B2
(en)
|
2011-08-16 |
2016-05-26 |
Tosho, Inc. |
Tablet splitting apparatus
|
|
US9428506B2
(en)
|
2012-04-14 |
2016-08-30 |
Intra-Cellular Therapies, Inc. |
Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for the treatment of nervous system disorders
|
|
BR112015005743A2
(pt)
|
2012-09-14 |
2017-07-04 |
Abbvie Deutschland |
derivados tricíclicos de quinoxalina e quinolina
|
|
WO2014145192A1
(en)
|
2013-03-15 |
2014-09-18 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
KR102967223B1
(ko)
|
2013-12-03 |
2026-05-19 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
신규한 방법
|
|
US9745300B2
(en)
|
2014-04-04 |
2017-08-29 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
KR20220054908A
(ko)
|
2014-04-04 |
2022-05-03 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
유기 화합물
|
|
EP3302442B1
(en)
|
2015-06-03 |
2024-10-16 |
Triastek, Inc. |
Dosage forms and use thereof
|
|
WO2017117514A1
(en)
|
2015-12-31 |
2017-07-06 |
Tung Roger D |
Deuterated iti-007
|
|
RU2743513C2
(ru)
|
2016-01-26 |
2021-02-19 |
Интра-Селлулар Терапиз, Инк. |
Органические соединения
|
|
IL281050B2
(en)
|
2016-03-25 |
2023-04-01 |
Intra Cellular Therapies Inc |
A controlled or delayed release pharmaceutical preparation containing a deuterated compound
|
|
US20200392135A1
(en)
|
2016-03-25 |
2020-12-17 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
WO2017172811A1
(en)
|
2016-03-28 |
2017-10-05 |
Intra-Cellular Therapies, Inc. |
Novel co-crystals
|
|
US10682354B2
(en)
|
2016-03-28 |
2020-06-16 |
Intra-Cellular Therapies, Inc. |
Compositions and methods
|
|
WO2017172784A1
(en)
|
2016-03-28 |
2017-10-05 |
Intra-Cellular Therapies, Inc. |
Novel salts and crystals
|
|
HUE057055T2
(hu)
|
2016-08-09 |
2022-04-28 |
Teva Pharmaceuticals Int Gmbh |
Lumateperon-ditozilátsó szilárd halmazállapotú formái
|
|
JP7013454B2
(ja)
|
2016-10-12 |
2022-02-15 |
イントラ-セルラー・セラピーズ・インコーポレイテッド |
アモルファス固体分散体
|
|
EP3562484B1
(en)
*
|
2016-12-29 |
2021-08-25 |
Intra-Cellular Therapies, Inc. |
Pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline derivatives useful in the treatment of cns disorders
|
|
WO2018126140A1
(en)
*
|
2016-12-29 |
2018-07-05 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
EP3600325A4
(en)
|
2017-03-24 |
2021-01-06 |
Intra-Cellular Therapies, Inc. |
UNIQUE COMPOSITIONS AND PROCESSES
|
|
WO2018189646A1
(en)
|
2017-04-10 |
2018-10-18 |
Dr. Reddy's Laboratories Limited |
AMORPHOUS FORM AND SOLID DISPERSIONS OF LUMATEPERONE p-TOSYLATE
|
|
WO2019023062A1
(en)
|
2017-07-26 |
2019-01-31 |
Intra-Cellular Therapies, Inc. |
ORGANIC COMPOUNDS
|
|
JP7224333B2
(ja)
|
2017-07-26 |
2023-02-17 |
イントラ-セルラー・セラピーズ・インコーポレイテッド |
有機化合物
|
|
WO2019067591A1
(en)
|
2017-09-26 |
2019-04-04 |
Intra-Cellular Therapies, Inc. |
NEW SALTS AND CRYSTALS
|
|
JP7401442B2
(ja)
|
2018-01-31 |
2023-12-19 |
イントラ-セルラー・セラピーズ・インコーポレイテッド |
新規使用
|
|
WO2019178484A1
(en)
|
2018-03-16 |
2019-09-19 |
Intra-Cellular Therapies, Inc. |
Novel methods
|
|
SMT202600133T1
(it)
|
2018-03-23 |
2026-05-12 |
Intra Cellular Therapies Inc |
Composti organici
|
|
AU2019240226B2
(en)
|
2018-03-23 |
2024-11-28 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
EP3801527B1
(en)
|
2018-06-08 |
2025-02-19 |
Intra-Cellular Therapies, Inc. |
Fused gamma-carbolines for acute treatment of anxiety or depression
|
|
RS67906B1
(sr)
|
2018-06-11 |
2026-04-30 |
Intra Cellular Therapies Inc |
Sinteza supstituisanih heterociklično fuzionisanih gama-karbolina
|
|
US20220160704A2
(en)
|
2018-08-08 |
2022-05-26 |
Torralva Medical Therapeutics Llc |
Compositions for opiate and opioid prevention and reversal, and methods of their use
|
|
US12144808B2
(en)
|
2018-08-29 |
2024-11-19 |
Intra-Cellular Therapies, Inc. |
Compositions and methods
|
|
AU2019328528B2
(en)
|
2018-08-31 |
2025-01-23 |
Intra-Cellular Therapies, Inc. |
Novel methods
|
|
WO2020047408A1
(en)
|
2018-08-31 |
2020-03-05 |
Intra-Cellular Therapies, Inc. |
Novel methods
|
|
KR20210104785A
(ko)
|
2018-12-17 |
2021-08-25 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
유기 화합물
|
|
US12331052B2
(en)
|
2018-12-21 |
2025-06-17 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
JP7377871B2
(ja)
*
|
2018-12-21 |
2023-11-10 |
イントラ-セルラー・セラピーズ・インコーポレイテッド |
有機化合物
|
|
CN118105390A
(zh)
|
2019-01-23 |
2024-05-31 |
细胞内治疗公司 |
治疗成瘾的方法
|
|
IL286938B1
(en)
|
2019-04-04 |
2026-05-01 |
Intra Cellular Therapies Inc |
Methods for treating neuropathic pain
|
|
WO2020223894A1
(en)
|
2019-05-07 |
2020-11-12 |
Nirsum Laboratories, Inc. |
Opioid receptor antagonist prodrugs
|
|
EP4134101A1
(en)
|
2019-07-07 |
2023-02-15 |
Intra-Cellular Therapies, Inc. |
Deuterated lumateperone for the treatment of the bipolar ii disorder
|
|
IL308750A
(en)
|
2021-06-07 |
2024-01-01 |
Intra Cellular Therapies Inc |
Novel salts and crystals
|
|
KR20240089771A
(ko)
|
2021-10-19 |
2024-06-20 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
신규한 방법
|